EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Gastrointestinal Barrier Disruption in Post‐ COVID Syndrome Fatigue Patients

Johanna Rohrhofer iD, Viktoria Wolflehner iD, Johannes Schweighardt, Larissa Koidl iD, Michael Stingl iD, Sonja Zehetmayer iD, Joana Séneca iD, Petra Pjevac iD, Eva Untersmayr iD

Allergy · 2025

DOI: 10.1111/all.16593 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Allergy, 2025. Verfasst von Johanna Rohrhofer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Aus…. Hauptthemen laut MEDLINE: COVID-19, Fatigue, Gastrointestinal Tract, Gastrointestinal Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: WE&ME Foundation, Medizinisch-Wissenschaftlicher Fond des Buergermeisters der Bundeshauptstadt Wien.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐COVID Syndrome (PCS) is the term for a condition with persistent symptoms in a proportion of COVID‐19 patients after asymptomatic, mild, or severe disease courses. Numbers vary, but the current estimate is that after COVID‐19 approximately 10% develop PCS. The aim of our study was to evaluate the impact of SARS‐CoV‐2 infection on the gastrointestinal (GI) tract and associations with the development of PCS with fatigue, post‐exertional malaise (PEM), orthostatic dysregulation, autonomous dysregulation, and/or neurocognitive dysregulation.

Methods

By combining medical record data from a prospective observational study with symptom analysis before, during, and after SARS‐CoV‐2 infection, we aimed to identify potential risk factors and predictive markers for PCS. Additionally, we analyzed blood, saliva, and stool samples from this well‐characterized PCS patient cohort to biologically validate our findings.

Results

We identified significant associations between pre‐existing GI complaints and the development of PCS Fatigue. PCS patients showed higher LBP/sCD14 ratios, lower IL‐33 levels, and higher IL‐6 levels compared to control groups. Our results highlight the critical role of the GI tract in PCS development of post‐viral Fatigue.

Conclusion

We propose that the viral infection disrupts pathways related to the innate immune response and GI barrier function, evidenced by intestinal low‐grade inflammation and GI barrier leakage. Monitoring GI symptoms and markers before, during, and after SARS‐CoV‐2 infection is crucial for identifying predictive clinical phenotypes in PCS. Understanding the interaction between viral infections, immune responses, and gut integrity could lead to more effective diagnostic and treatment strategies, ultimately reducing the burden on PCS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19FatigueGastrointestinal TractGastrointestinal DiseasesHumansMaleFemaleMiddle AgedSARS-CoV-2Prospective StudiesAdultAgedPost-Acute COVID-19 SyndromeRisk FactorsBiomarkers

Stichwörter der Autor:innen

gastrointestinal barrier functionimmune barrierpost‐COVID syndromepost‐viral fatiguepredictive phenotypes

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Facharztzentrum Votivpark, Vienna, Austria.
  • Institute of Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna, Vienna, Austria.
  • Division of Microbial Ecology, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.
  • Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Johanna Rohrhofer, Viktoria Wolflehner, Larissa Koidl, Michael Stingl, Sonja Zehetmayer, Joana Séneca, Petra Pjevac, Eva Untersmayr

Förderung

  • WE&ME Foundation
  • Medizinisch-Wissenschaftlicher Fond des Buergermeisters der Bundeshauptstadt Wien

Zitieren

APA

Rohrhofer, J., Wolflehner, V., Schweighardt, J., Koidl, L., Stingl, M., Zehetmayer, S., Séneca, J., Pjevac, P., & Untersmayr, E. (2025). Gastrointestinal Barrier Disruption in Post‐ COVID Syndrome Fatigue Patients. Allergy. https://doi.org/10.1111/all.16593

Vancouver

Rohrhofer J, Wolflehner V, Schweighardt J, Koidl L, Stingl M, Zehetmayer S, et al. Gastrointestinal Barrier Disruption in Post‐ COVID Syndrome Fatigue Patients. Allergy. 2025. doi:10.1111/all.16593

BibTeX
@article{Rohrhofer2025,
  author = {Rohrhofer, Johanna and Wolflehner, Viktoria and Schweighardt, Johannes and Koidl, Larissa and Stingl, Michael and Zehetmayer, Sonja and Séneca, Joana and Pjevac, Petra and Untersmayr, Eva},
  title = {Gastrointestinal Barrier Disruption in Post‐ COVID Syndrome Fatigue Patients},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16593}
}
Kostenlos starten →